Recombinant ADAMTS‑1 promotes muscle regeneration accompanied by downregulation of Notch signaling
International Journal of Molecular Medicine · 2025
DOI: 10.3892/ijmm.2025.5718 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Jin-Hwa Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, College of Veterinary Medicine (BK21 FOUR Program), Chungnam National University, Daejeon 34131, Republic of Korea. Hauptthemen laut MEDLINE: Regeneration, Signal Transduction, Muscle, Skeletal, ADAMTS1 Protein. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Skeletal muscle satellite cells (MuSCs) play a central role in muscle regeneration; however, their capacity declines with age, contributing to sarcopenia. A disintegrin and metalloproteinase with thrombospondin motifs‑1 (ADAMTS‑1) regulates MuSC activation and differentiation. The present study aimed to investigate the potential of recombinant ADAMTS‑1 (rADAMTS‑1) as a therapeutic strategy to enhance MuSC proliferation and improve regeneration. After barium chloride injection, mice received daily intraperitoneal injections of rADAMTS‑1 at 5 or 10 mg/kg for 1, 3, 7, or 14 days to monitor recovery. Primary skeletal muscle and C2C12 cells were also treated with rADAMTS‑1 to evaluate its effects on gene and protein expression during proliferation and differentiation in vitro. The number of MuSCs and the expression of myogenic markers increased in all injured groups by day 3 post‑injury in vivo. These levels were particularly elevated in the high‑dose rADAMTS‑1 group and remained sustained until day 14. Grip strength recovered to normal levels by day 7 in the high‑dose rADAMTS‑1 group, suggesting improved functional recovery compared with the untreated controls. In vitro, rADAMTS‑1 treatment induced a dose‑dependent increase in muscle fiber length and upregulation of regeneration‑related factors in primary skeletal muscle cells. Furthermore, C2C12 cells treated with rADAMTS‑1 exhibited enhanced expression of myocyte developmental genes during differentiation. The findings highlighted the therapeutic potential of rADAMTS‑1 for sarcopenia, potentially addressing limitations associated with conventional MuSC‑based treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medicine, College of Veterinary Medicine (BK21 FOUR Program), Chungnam National University, Daejeon 34131, Republic of Korea.
- Nuon Bio Co., Ltd., Seongnam, Gyeonggi 13201, Republic of Korea.
Zitieren
APA
Kim, J. H., Lee, S. H., Kim, S. Y., Kim, J. W., Jeong, J. S., Chung, E. H., Lee, S. H., Kim, C. Y., Choi, B. K., Ko, J. W., & Kim, T. W. (2025). Recombinant ADAMTS‑1 promotes muscle regeneration accompanied by downregulation of Notch signaling. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5718
Vancouver
Kim JH, Lee SH, Kim SY, Kim JW, Jeong JS, Chung EH, et al. Recombinant ADAMTS‑1 promotes muscle regeneration accompanied by downregulation of Notch signaling. International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5718
BibTeX
@article{Kim2025,
author = {Kim, Jin-Hwa and Lee, Sang-Hyup and Kim, Sang-Yoon and Kim, Jeong-Won and Jeong, Ji-Soo and Chung, Eun-Hye and Lee, Su-Ha and Kim, Chang-Yeop and Choi, Bong-Keun and Ko, Je-Won and Kim, Tae-Won},
title = {Recombinant ADAMTS‑1 promotes muscle regeneration accompanied by downregulation of Notch signaling},
journal = {International Journal of Molecular Medicine},
year = {2025},
doi = {10.3892/ijmm.2025.5718}
}
EUVIMED